These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 12378864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin II-receptor antagonists: an overview.
    Dina R, Jafari M.
    Am J Health Syst Pharm; 2000 Jul 01; 57(13):1231-41. PubMed ID: 10902066
    [Abstract] [Full Text] [Related]

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 01; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 01; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. Comparative antihypertensive effects of angiotensin II receptor antagonists.
    Burnier M, Brunner HR.
    J Am Soc Nephrol; 1999 Apr 01; 10 Suppl 12():S278-82. PubMed ID: 10201883
    [Abstract] [Full Text] [Related]

  • 7. [Comparison with other antihypertensive drugs, especially with ACEI].
    Hiwada K.
    Nihon Rinsho; 1999 May 01; 57(5):1187-93. PubMed ID: 10361454
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin II receptor antagonists role in arterial hypertension.
    Hernández-Hernández R, Sosa-Canache B, Velasco M, Armas-Hernández MJ, Armas-Padilla MC, Cammarata R.
    J Hum Hypertens; 2002 Mar 01; 16 Suppl 1():S93-9. PubMed ID: 11986904
    [Abstract] [Full Text] [Related]

  • 11. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V, Buksa M, Loza V, Kulic M.
    Med Arh; 2009 Mar 01; 63(6):343-9. PubMed ID: 20380117
    [Abstract] [Full Text] [Related]

  • 12. Experience with angiotensin II antagonists in hypertensive patients.
    Waeber B, Burnier M, Nussberger J, Brunner HR.
    Clin Exp Pharmacol Physiol; 1996 Sep 01; 23 Suppl 3():S142-6. PubMed ID: 21143288
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
    Ellis ML, Patterson JH.
    Pharmacotherapy; 1996 Sep 01; 16(5):849-60. PubMed ID: 8888079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. RAS inhibition in hypertension.
    Ibrahim MM.
    J Hum Hypertens; 2006 Feb 01; 20(2):101-8. PubMed ID: 16397519
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Valsartan: new preparation. Just a second-line antihypertensive drug.
    Prescrire Int; 1998 Oct 01; 7(37):144-5. PubMed ID: 10915419
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.